PATENT CLAIM ANALYSIS

Application Number: 16222155
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "133100"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of combinations of immunomodulatory polynucleotides (e.g., mRNAs) encoding an immune response primer polypeptide (e.g., an interleukin 23 (IL-23) polypeptide or an interleukin 36γ (IL-36-gamma) polypeptide), and an immune response co-stimulatory signal polypeptide (e.g., an OX40L polypeptide).

Claim (Index 14):
The lipid nanoparticle of  claim 13 , wherein the at least one microRNA binding site is a miR-122 binding site.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.73684
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16184282', '16219418', '15995889', '16192274', '15996146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.862913914696245
- 35 USC 102 Novelty (BERT): 0.6540490406446031
- Combined Prediction Score: 0.8420274272910808
- Mean Citation Score: 685.9833299999998
- Max Citation Score: 814.3477
- Similarity Product: 587.1994078606367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test